{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T15:10:57Z","timestamp":1723821057066},"reference-count":26,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2022]]},"DOI":"10.3960\/jslrt.22005","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T22:10:05Z","timestamp":1660774205000},"page":"169-174","source":"Crossref","is-referenced-by-count":2,"title":["Surface CD3-negative monomorphic epitheliotropic intestinal T-cell lymphoma"],"prefix":"10.3960","volume":"62","author":[{"given":"Hideharu","family":"Domoto","sequence":"first","affiliation":[{"name":"Department of Diagnostic Pathology, Keiyu Hospital, Yokohama, Kanagawa, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Araki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Keiyu Hospital, Yokohama, Kanagawa, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuka","family":"Ogai","sequence":"additional","affiliation":[{"name":"Department of Hematology, Keiyu Hospital, Yokohama, Kanagawa, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Inukai","sequence":"additional","affiliation":[{"name":"Department of Surgery, Keiyu Hospital, Yokohama, Kanagawa, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien K","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Keiyu Hospital, Yokohama, Kanagawa, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakura","family":"Tomita","sequence":"additional","affiliation":[{"name":"Department of Pathological Diagnostics, Tokai University School of Medicine, Isehara, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Mukai","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Keiyu Hospital, Yokohama, Kanagawa, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Pathological Diagnostics, Tokai University School of Medicine, Isehara, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Chan JKC, Fukayama M. Haematolymphoid tumours of digestive system: Introduction. In : The WHO Classification of Tumours Editorial Board (eds) : Digestive System Tumours. Lyon (France), International Agency for Research on Cancer. 2019; pp. 376-377."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Howell JM, Auer-Grzesiak I, Zhang J <i>et al.<\/i> Increasing incidence rates, distribution and histological characteristics of primary gastrointestinal non-Hodgkin lymphoma in a North American population. Can J Gastroenterol. 2012; 26: 452-456.","DOI":"10.1155\/2012\/480160"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Olszewska-Szopa M, Wr\u00f3bel T. Gastrointestinal non-Hodgkin lymphomas. Adv Clin Exp Med. 2019; 28: 1119-1124.","DOI":"10.17219\/acem\/94068"},{"key":"4","unstructured":"4 Jaffe ES, Bhagat G, Chott A, et al. Intestinal T-cell lymphoma. In : The WHO Classification of Tumours Editorial Board (eds) : Digestive System Tumours. Lyon (France), International Agency for Research on Cancer. 2019; pp. 372-380."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Chan JKC, Chan ACL, Cheuk W <i>et al.<\/i> Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent \u03b3\u03b4 T-cell receptor expression. Am J Surg Pathol. 2011; 35: 1557-1569.","DOI":"10.1097\/PAS.0b013e318222dfcd"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Susan SSH, Ng SB, Wang S, Tan SY. Diagnostic approach to T- and NK-cell lymphoproliferative disorders in the gastrointestinal tract. Semin Diagn Pathol. 2021; 38: 21-30.","DOI":"10.1053\/j.semdp.2021.03.004"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Tang XF, Yang L, Duan S, Guo H, Guo QN. Intestinal T-cell and NK\/T-cell lymphomas: A clinicopathological study of 27 Chinese patients. Ann Diagn Pathol. 2018; 37: 107-117.","DOI":"10.1016\/j.anndiagpath.2018.10.004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Jhuang JY, Chang ST, Weng SF <i>et al.<\/i> Extranodal natural killer\/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors. Hum Pathol. 2015; 46: 313-321.","DOI":"10.1016\/j.humpath.2014.11.008"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Chuang SS, Jung YC. Natural killer cell lymphoma of small intestine with features of enteropathy but lack of association with celiac disease. Hum Pathol. 2004; 35: 639-642.","DOI":"10.1016\/j.humpath.2004.01.013"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Fujiwara H, Akiyama T, Nishimura H <i>et al.<\/i> Primary intestinal NK-cell lymphoma with a CD8+ CD56+ immunophenotype: a case report. Pathol Int. 2013; 63: 138-140.","DOI":"10.1111\/pin.12034"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Aoyama Y, Tsunemine H, Zushi Y <i>et al.<\/i> Colonal monomorphic epitheliotropic intestinal T-cell lymphoma with novel phenotype of cytoplasmic CD3 expression. J Clin Exp Hematop. 2018; 58: 102-106.","DOI":"10.3960\/jslrt.18002"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Tan SY, Chuang SS, Tang T <i>et al.<\/i> Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8\u03b1\u03b1 phenotype. Leukemia. 2013; 27: 1688-1696.","DOI":"10.1038\/leu.2013.41"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Li Y, Wei J, Mao X <i>et al.<\/i> Flow Cytometric immunophenotyping is sensitive for the early diagnosis of de novo aggressive natural killer cell leukemia (ANKL): a multicenter retrospective analysis. PLoS One. 2016; 11: e0158827.","DOI":"10.1371\/journal.pone.0158827"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 McKinney EF, Cuthbertson I, Harris KM <i>et al.<\/i> A CD8+ NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis. Nat Commun. 2021; 12: 635.","DOI":"10.1038\/s41467-020-20594-2"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Craig JW, Dorfman DM. Flow Cytometry of T cells and T-cell neoplasms. Clin Lab Med. 2017; 37: 725-751.","DOI":"10.1016\/j.cll.2017.07.002"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Kato A, Takiuchi Y, Aoki K <i>et al.<\/i> Enteropathy-associated T-cell lymphoma type II complicated by autoimmune hemolytic anemia. J Clin Exp Hematop. 2011; 51: 119-123.","DOI":"10.3960\/jslrt.51.119"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Tanaka H, Ambiru S, Nakamura S <i>et al.<\/i> Successful diagnosis of type II enteropathy-associated T-cell lymphoma using flow cytometry and the cell block technique of celomic fluid manifesting as massive pyoid ascites that could not be diagnosed via emergency laparotomy. Intern Med. 2014; 53: 129-133.","DOI":"10.2169\/internalmedicine.53.1268"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Antoniadou F, Dimitrakopoulou A, Voutsinas PM <i>et al.<\/i> Monomorphic epitheliotropic intestinal T-cell lymphoma in pleural effusion: A case report. Diagn Cytopathol. 2017; 45: 1050-1054.","DOI":"10.1002\/dc.23772"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Roberti A, Dobay MP, Bisig B <i>et al.<\/i> Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations. Nat Commun. 2016; 7: 12602.","DOI":"10.1038\/ncomms12602"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Nairism\u00e4gi ML, Tan J, Lim JQ <i>et al.<\/i> JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma. Leukemia. 2016; 30: 1311-1319.","DOI":"10.1038\/leu.2016.13"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Tomita S, Kikuti YY, Carreras J <i>et al.<\/i> Monomorphic epitheliotropic intestinal T-cell lymphoma in Asia frequently shows SETD2 alterations. Cancers (Basel). 2020; 12: 3539.","DOI":"10.3390\/cancers12123539"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Calabretta E, Carlo-Stella C. The Many facets of CD38 in Lymphoma: from tumor\u2013microenvironment cell interactions to acquired resistance to immunotherapy. Cells. 2020; 9: 802.","DOI":"10.3390\/cells9040802"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Damle RN, Wasil T, Fais F <i>et al.<\/i> Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999; 94: 1840-1847.","DOI":"10.1182\/blood.V94.6.1840"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Zaja F, Tabanelli V, Agostinelli C <i>et al.<\/i> CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: possible biomarkers for novel targeted therapies? Am J Hematol. 2017; 92: E1-E2.","DOI":"10.1002\/ajh.24571"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Wang L, Wang H, Li PF <i>et al.<\/i> CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK\/T cell lymphoma, nasal type. Ann Hematol. 2015; 94: 1381-1388.","DOI":"10.1007\/s00277-015-2359-2"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Hari P, Raj RV, Olteanu H. Targeting CD38 in refractory extranodal natural killer cell- T-cell lymphoma. N Engl J Med. 2016; 375: 1501-1502.","DOI":"10.1056\/NEJMc1605684"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/62\/3\/62_22005\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T05:18:38Z","timestamp":1664601518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/62\/3\/62_22005\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.22005","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"22005"}}